According to Sino Biopharmaceutical's latest financial reports the company has a price-to-book ratio of 1.29.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.66 | -17.68% |
2022-12-31 | 2.02 | -9.39% |
2021-12-31 | 2.23 | -58.32% |
2020-12-31 | 5.34 | -10.72% |
2019-12-31 | 5.99 | 86.29% |
2018-12-31 | 3.21 | -52.61% |
2017-12-31 | 6.78 | 99.78% |
2016-12-31 | 3.39 | -32.2% |
2015-12-31 | 5.01 | 27.28% |
2014-12-31 | 3.93 | -6.39% |
2013-12-31 | 4.20 | 33.05% |
2012-12-31 | 3.16 | 32.23% |
2011-12-31 | 2.39 | -30.03% |
2010-12-31 | 3.41 | -8.77% |
2009-12-31 | 3.74 |